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arrhythmias and has been shown to increase the risk of nocturnal SCD. It is unknown if OSA independently increases
the risk of SCD.Methods We included 10,701 consecutive adults undergoing their ﬁrst diagnostic polysomnogram between July 1987 and
July 2003. During follow-up up to 15 years, we assessed incident resuscitated or fatal SCD in relation to the
presence of OSA, physiological data including the apnea-hypopnea index (AHI), and nocturnal oxygen saturation
(O2sat) parameters, and relevant comorbidities.Results During an average follow-up of 5.3 years, 142 patients had resuscitated or fatal SCD (annual rate 0.27%). In
multivariate analysis, independent risk factors for SCDwere age, hypertension, coronary artery disease, cardiomyopathy
or heart failure, ventricular ectopy or nonsustained ventricular tachycardia, and lowest nocturnal O2sat (per 10%
decrease, hazard ratio [HR]: 1.14; p ¼ 0.029). SCD was best predicted by age >60 years (HR: 5.53), apnea-hypopnea
index >20 (HR: 1.60), mean nocturnal O2sat <93% (HR: 2.93), and lowest nocturnal O2sat <78% (HR: 2.60; all
p < 0.0001).Conclusions In a population of 10,701 adults referred for polysomnography, OSA predicted incident SCD, and the magnitude of
risk was predicted by multiple parameters characterizing OSA severity. Nocturnal hypoxemia, an important
pathophysiological feature of OSA, strongly predicted SCD independently of well-established risk factors. These
ﬁndings implicate OSA, a prevalent condition, as a novel risk factor for SCD. (J Am Coll Cardiol 2013;62:610–6)
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13; revised manuscript received April 7, 2013,stratiﬁcation is difﬁcult, as modern therapies after myocar-
dial infarction have altered the prognostic power of many
risk factors and because the vast majority of SCD occurs in
people without recognized heart disease (2). Recent pop-
ulation studies suggest that the risk of SCD is largely
unrelated to traditional risk factors and may involve yet-
unrecognized variables that directly affect cardiac function
and arrhythmogenesis (3,4).
Obstructive sleep apnea (OSA) may be one such unrec-
ognized risk factor for SCD (5). A growing body of evidence
conﬁrms strong associations between OSA and cardiovas-
cular diseases, including coronary artery disease, hyperten-
sion, left ventricular dysfunction, and arrhythmias (6). OSA
is also associated with increased mortality (7,8). A speciﬁc
link to SCD was suggested by the ﬁnding that SCD is more
likely to occur during usual sleep hours in individuals with
OSA, which is the time when SCD is least likely in indi-
viduals without OSA and in the general population (9).
Abbreviations
and Acronyms
AHI = apnea-hypopnea index
CI = conﬁdence interval
HR = hazard ratio
ICD = implantable
cardioverter-deﬁbrillator
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611Even though these data demonstrated that individuals with
OSA experience an altered day-night pattern of SCD,
whether OSA increases the overall risk of SCD is not
known.
We hypothesized that OSA is associated with an
increased risk of SCD independently of other risk factors
and that the severity of OSA is directly associated with the
magnitude of this risk.OSA = obstructive sleep
apnea
SCD = sudden cardiac death
Methods
The Mayo Foundation Institutional Review Board approved
the study, and only individuals who authorized their records
to be used for research were included. Data were collected
from medical records by dedicated cardiovascular research
studies unit personnel trained speciﬁcally for this study.
Standardized, piloted forms were used for data collection,
and quality was maintained by direct supervision and feed-
back by a study physician. A validation series using data
from 200 subjects demonstrated agreement (Cohen kappa ¼
0.91) between data collected separately by a study physician
and the research personnel (10).
Subjects. The study population was derived from all indi-
viduals referred for sleep studies to the Mayo Clinic Sleep
Disorders Center between July 1, 1987, and July 31, 2003.
The indication for sleep studies in the vast majority of
subjects was suspected sleep-disordered breathing, and this
remained constant during the study period. We limited the
study sample to Minnesota residents who were 18 years or
older and undergoing their ﬁrst-ever overnight sleep study
(polysomnogram), which necessarily excluded individuals
with a prior diagnosis of OSA. We also excluded individuals
with a history of resuscitated SCD.
Data collected at the time of polysomnography included
variables that have previously been associated with SCD.
These included subjects’ age, sex, body mass index, and
comorbidities. Coronary artery disease was conﬁrmed if
the medical record noted a history of angina, myocardial
infarction, abnormal cardiac stress or perfusion study, cor-
onary angiogram revealing 1 stenoses 70%, percutaneous
coronary intervention, or coronary artery bypass graft surgery.
Cardiomyopathy or heart failure was conﬁrmed if the medical
record documented the presence of cardiomyopathy or clinical
heart failure, or if any cardiac imaging study demonstrated
a left ventricular ejection fraction <50%. Diabetes mellitus
was conﬁrmed if themedical record noted the presence of type
1 or type 2 diabetesmellitus or the use of diabetesmedications.
Hypertension, strokes, transient ischemic attacks, complex
ventricular ectopy or nonsustained ventricular tachycardia,
prior smoking, and presence of an implantable cardioverter-
deﬁbrillator (ICD) were conﬁrmed if the diagnosis was
established in the medical record. We did not collect
numerical data, such as cholesterol levels, blood pressures, or
number of cigarettes smoked. Due to the retrospective
methodology, the presence and effects of treatment forthese conditions, and the develop-
ment or resolution of these condi-
tions during follow-up, were not
measured.
Polysomnography. All individ-
uals’ sleep evaluations were con-
ducted by a board-certiﬁed sleep
specialist at the Mayo Clinic Sleep
Disorder Center. We reviewed
each individual’s ﬁrst diagnostic
polysomnogram, which included
measures of the electroencepha-
logram, electro-oculogram, electromyogram, electrocardio-
gram, thoracoabdominal excursions, pulse oximetry, and
naso-oral airﬂow. The apnea-hypopnea index (AHI) was
calculated as the sum of apneas and hypopneas per hour of
sleep. We also collected the awake oxygen saturation, mean
nocturnal oxygen saturation, lowest nocturnal oxygen
saturation, arousal index, and sleep efﬁciency. According to
American Academy of Sleep Medicine criteria, an AHI 5
established the diagnosis of OSA (11).
Follow-up. The collection of follow-up data and conﬁr-
mation of the primary outcome were performed blinded to
the collection of baseline and polysomnographic data and
classiﬁcation of OSA. Follow-up data were obtained for
each subject from the date of polysomnography to the date
of SCD or resuscitated SCD (see deﬁnitions), death from
other causes, or last follow-up through December 31, 2003,
ascertained with the Mayo Clinic electronic medical record,
the Minnesota Department of Health database, and the
National Death Index. To ascertain the use of continuous
positive airway pressure therapy during follow-up, we
considered that continuous positive airway pressure was used
by a subject if it was prescribed after the sleep study and if
the medical record subsequently conﬁrmed its use. Due to the
retrospective methodology, we could not quantify compliance
with or effectiveness of continuous positive airway pressure
therapy during follow-up.
Classiﬁcation of SCD. The primary outcome of the study
was fatal or resuscitated SCD. Manual review of death
certiﬁcates and data from the Minnesota Department of
Health provided the immediate and underlying causes of
death. A state nosologist used the methods of the National
Center for Health Statistics to assign causes of death. SCD
was established when the cause of death was sudden cardiac
death, (fatal) cardiac dysrhythmia, (fatal) cardiac arrhythmia,
cardiac arrest, cardiorespiratory arrest, or coronary heart
disease or myocardial infarction when the time interval from
symptoms to death was speciﬁed 1 h. SCD was excluded if
the medical record or death certiﬁcate provided information
that explicitly contradicted this deﬁnition of SCD: “natural
death due to cardiac causes, heralded by abrupt loss of
consciousness within one hour of the onset of acute symp-
toms; preexisting heart disease may have been known to be
present, but the time and mode of death are unexpected” and
nontraumatic (12). The occurrence of SCD during sleep was
Table 1 Baseline Characteristics of Study Population
Age, yrs 53  14
Male 68
Body mass index, kg/m2 34  9
Smoking history 57
Diabetes mellitus 14
Hypertension 41
Stroke or transient ischemic attack 5
Coronary artery disease 14
Cardiomyopathy or heart failure 6
Ventricular ectopy or nonsustained ventricular tachycardia 0.4
Implanted ICD 0.1
Values are mean  SD or %.
ICD ¼ implantable cardioverter-deﬁbrillator.
Table 2
Results of Diagnostic Polysomnography in the
Study Population
Obstructive sleep apnea 78
Central sleep apnea 0.03
Sleep efﬁciency, % 74  17
Arousal index, events/h 38  28
Apnea-hypopnea index, events/h 31  32
Awake oxygen saturation, % 95  4
Mean nocturnal oxygen saturation, % 93  3
Lowest nocturnal oxygen saturation, % 82  11
Values are % or mean  SD.
Gami et al. JACC Vol. 62, No. 7, 2013
Sleep Apnea and Sudden Death August 13, 2013:610–6
612an exception to the criteria for “loss of consciousness within
1 h of the acute onset of symptoms.”
Resuscitated SCD included out-of-hospital and in-
hospital resuscitated cardiac arrest, as well as the ﬁrst-ever
delivery of appropriate ICD therapy for ventricular tachy-
cardia or ventricular ﬁbrillation. By deﬁnition, the latter
instances occurred in subjects with ICD implanted for
primary prevention of SCD, because individuals with
previous SCD were excluded from the study sample.
Statistical analysis. Analyses were performed using SAS
Proprietary Software (release 8.2, SAS Institute, Cary,
North Carolina). A 2-sided p value <0.05 was considered
statistically signiﬁcant for all analyses.
Baseline characteristics of the study population were
described by counts (percentages), mean  SD, or medians
(interquartile ranges). Kaplan-Meier time-to-event analyses
were performed to identify univariate predictors of SCD.
Multivariate time-to-event analyses were performed using Cox
proportional hazards regression to identify independent
predictors of SCD.Astepwise parsimonious selection technique
constructed a model with the possible parameters of age, sex,
body mass index, obesity (body mass index 30 kg/m2),
smoking history, hypertension, diabetes, coronary artery disease,
cardiomyopathy or heart failure, and ventricular arrhythmias.
To assess the risk of SCD posed by OSA, the following
parameters were included into the model independently: OSA
status, AHI, awake oxygen saturation, lowest nocturnal oxygen
saturation, and mean nocturnal oxygen saturation.
We also performed classiﬁcation and regression tree
analyses to identify thresholds of relevant continuous vari-
ables that had the best discriminative power for predicting
SCD. These analyses found the following thresholds: AHI
20; and lowest nocturnal oxygenation saturation 78%. These
dichotomized variables were introduced into the univariate
and multivariate models. A pre-determined subgroup of
patients with OSA was created to assess the effects of
continuous positive airway pressure therapy.
Results
The study sample consisted of 10,701 adult residents of
Minnesota, whose baseline characteristics are described in
Table 1. Results of subjects’ polysomnographies are de-
scribed in Table 2. Follow-up occurred up to 15 years and
averaged 5.3 years. During this time, 142 subjects had fatal
or resuscitated SCD, which reﬂects an averaged annual risk
of SCD of 0.27% for the study population. SCD was due
to an unidentiﬁable or nondeﬁnitive cause (due to out-of-
hospital death and lack of autopsy) in 58 subjects, deﬁnite
ventricular arrhythmia in 44 subjects, acute myocardial
infarction in 18 subjects, massive pulmonary embolism in 1
subject, and resuscitated SCD (either via ICD therapy or
advanced cardiac life support) in 21 subjects.
Clinical predictors and sleep parameters that predicted
SCD in univariate analyses are shown in Table 3. Classiﬁ-
cation and regression tree analyses found that SCD was bestpredicted by these thresholds for the following continuous
variables: age 60 years (hazard ratio [HR]: 5.53, 95%
conﬁdence interval [CI]: 3.84 to 7.94; p < 0.0001), AHI 20
(HR: 1.60, 95% CI: 1.14 to 2.24; p ¼ 0.007) (Fig. 1), mean
nocturnal oxygen saturation 93% (HR: 2.93, 95% CI: 1.98
to 4.33; p < 0.0001), and lowest oxygen saturation 78%
(HR: 2.60, 95% CI: 1.85 to 3.65; p < 0.0001) (Fig. 2).
Risk factors for SCD in the multivariate analyses are
shown in Table 4. In multivariate analysis, the classiﬁcation
and regression tree–determined lowest nocturnal oxygen
saturation of 78% had an HR for SCD of 1.81 (95% CI:
1.28 to 2.56; p ¼ 0.0008). The baseline characteristics of the
pre-determined subgroup of OSA patients is shown in
Table 5, and the results of multivariate analyses in this
subgroup are shown in Table 6.
Discussion
The principal and novel ﬁndings of the present study are
that in a population of 10,701 adults referred for sleep
studies, the presence of OSA predicted incident SCD and
the magnitude of risk was predicted by multiple parameters
that characterize OSA severity, including the AHI and
nocturnal oxygen desaturation. Notably, the severity of
nocturnal hypoxemia, which is an important pathophysio-
logical feature of OSA, strongly predicted SCD indepen-
dently of other well-established risk factors. Our analysis
showed that for the lowest nocturnal oxygen saturation, the
best discriminating threshold of 78% predicts an 81%
increase in the risk of SCD.
Figure 1 Survival Based on AHI
Survival free of fatal or resuscitated sudden cardiac death (SCD) in the total study
population, based on the apnea-hypopnea index (AHI) threshold determined by
classiﬁcation and regression tree analysis (AHI <20 vs. AHI 20). Hazard ratio:
1.60, 95% conﬁdence interval: 1.14 to 2.24; p ¼ 0.007.
Table 3 Univariate Predictors of SCD
HR 95% CI p Value
Age, per 1 yr 1.07 1.05–1.08 <0.001
Male 1.78 1.18–2.70 0.006
Body mass index, per 1 kg/m2 1.00 0.98–1.02 0.845
Obesity, body mass index 30 kg/m2 1.02 0.72–1.45 0.903
Smoking history 2.19 1.06–4.5 0.034
Diabetes mellitus 4.10 2.9–5.8 <0.001
Hypertension 3.63 2.5–5.2 <0.001
Stroke or transient ischemic attack 4.65 3.03–7.1 <0.001
Coronary artery disease 14.53 10.22–20.66 <0.001
Cardiomyopathy or heart failure 22.62 16.23–31.51 <0.001
Ventricular ectopy or NSVT 18.63 9.79–35.45 <0.001
Implanted ICD 59.09 18.70–186.68 <0.001
Sleep parameters
Sleep efﬁciency, per 10% decrease 1.20 1.09–1.30 <0.001
Arousal index, per 10 events/h 1.09 1.05–1.14 <0.001
Apnea-hypopnea index, per 10 events/h 1.05 1.0–1.09 0.038
Awake O2 saturation, per 10% decrease 1.33 1.13–1.55 <0.001
Mean nocturnal O2 saturation,
per 10% decrease
2.33 1.72–3.14 <0.001
Lowest nocturnal O2 saturation,
per 10% decrease
1.30 1.16–1.44 <0.001
CI ¼ conﬁdence interval(s); HR ¼ hazard ratio; ICD ¼ implantable cardioverter-deﬁbrillator; NSVT ¼ nonsustained ventricular
tachycardia; SCD ¼ sudden cardiac death.
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613Biological plausibility. There is a cascade of possible
pathophysiological mechanisms linking OSA to SCD
during the daytime and during sleep (6). Obstructive apneic
events cause systemic hypoxemia, which is sometimes severe
and prolonged. These repetitive oxygen desaturations in
OSA patients may cause ventricular ectopy. Hypoxemia,
with associated hypercapnia, also activates the chemoreﬂex,
which increases vascular sympathetic nerve activity and
serum catecholamines. Tachycardia and surges in blood
pressure at the end of apneas result in increased myocardial
oxygen demand at a time when oxygen saturation is at its
lowest, a situation that may lead to myocardial ischemia and
potentially dysrhythmic consequences. Individuals with
OSA also have a paradoxical increase in coagulability during
the night. Platelet activation and aggregation are increased,
ﬁbrinogen levels are increased, and ﬁbrinolytic activity is
decreased during sleep in patients with OSA.
An increased risk of SCD in individuals withOSAmay also
be explained by cardiac autonomic dysfunction. OSA affects
mechanisms mediating heart rate variability, including central
nervous system coupling between cardiac and ventilatory
parasympathetic inputs, the arterial baroreﬂex, and feedback
from pulmonary stretch receptors (13). As a result, heart rate
variability is decreased in patients with OSA (14). In addition,
the electrocardiographic corrected QT interval, which repre-
sents the duration of ventricular repolarization, and corrected
QT interval dispersion, which reﬂects the heterogeneity of
repolarization, are abnormal in patients with OSA. Corrected
QT interval dispersion correlates directly with the AHI and
the duration of nocturnal hypoxemia (15). Furthermore, the
increase in sympathetic drive persists during the awakedaytime period in individuals with OSA (16). Although the
precise link between autonomic function and SCD remain
largely unknown (17), chronic sympathetic overdrive has been
identiﬁed as a risk marker for SCD (18). Also, OSA is present
in a large proportion of patients with heart failure, and has
been implicated in chronic left ventricular dysfunction
(19,20), thus contributing to neurohumoral activation and
myocardial remodeling that produce the substrate for SCD.
Table 5
Baseline Characteristics of the Subgroup of
Patients With OSA (N ¼ 8,327)
Number of primary outcomes, SCD or resuscitated SCD 98 (1.2)
Age, yrs 54  17
Male 74
Body mass index, kg/m2 35  9
Smoking history 59
Diabetes mellitus 15
Hypertension 45
Stroke or transient ischemic attack 5
Coronary artery disease 15
Cardiomyopathy or heart failure 6
Ventricular ectopy or NSVT 0.4
Implanted ICD 0.1
Obstructive sleep apnea, AHI 5 100
Apnea-hypopnea index 38  32
Awake O2sat, % 95  4
Mean nocturnal O2sat, % 93  3
Lowest nocturnal O2sat, % 80  11
Values are n (%), mean  SD, or %.
AHI ¼ apnea-hypopnea index; OSA ¼ obstructive sleep apnea; O2sat ¼ oxygen saturation;
other abbreviations as in Tables 1 and 3.
Figure 2 Survival Based on O2sat
Survival free of fatal or resuscitated sudden cardiac death (SCD) in the total study
population, based on the lowest nocturnal oxygen saturation (O2sat) threshold
determined by classiﬁcation and regression tree analysis (78% vs. <78%). In
multivariate analysis, hazard ratio ¼ 1.81, 95% conﬁdence interval: 1.28 to 2.56;
p ¼ 0.0008.
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614Previous studies. A controlled, multicenter study showed
that during sleep nonsustained ventricular tachycardia
occurred in 5.3% and complex ventricular ectopy occurred in
25% of patients with sleep-disordered breathing, which
included OSA as well as central sleep apnea (21). After
adjustment for comorbidities, patients with sleep-disordered
breathing had a 3.4-fold risk of nonsustained ventricular
tachycardia and a 1.7-fold risk of complex ventricular activity
compared with patients with normal sleep. The only previous
controlled longitudinal study assessing the risk of SCD in
patients with OSA compared the rate of SCD after an average
of 7.5 years in 107 OSA patients who were compliant with
continuous positive airway pressure therapy and 61 OSA
patients who had discontinued therapy. SCD occurred in 4
patients (7%) with untreated OSA and in no patients (0%)
with treated OSA (there was 1 arrhythmic death in a treatedTable 4
Independent Predictors of SCD in the Total Study
Population (Results of Multivariate Regression)
HR 95% CI p Value
Age, yrs 1.02 1.01–1.04 0.005
Hypertension 1.48 1.02–2.15 0.04
Coronary artery disease 4.76 3.14–7.22 <0.001
Cardiomyopathy or heart failure 7.32 4.99–10.73 <0.001
Ventricular ectopy or NSVT 3.34 1.73–6.43 <0.001
Sleep parameters
Apnea-hypopnea index, per 10 1.03 0.98–1.08 0.281
Mean nocturnal O2 saturation,
per 10%
1.49 0.96–2.28 0.073
Lowest nocturnal O2 saturation,
per 10%
1.14 1.01–1.27 0.029
Abbreviations as in Table 3.patient during coronary bypass surgery) (22). Additional
observations supporting the inﬂuence of OSA on the occur-
rence of SCD are the strikingly different day-night patterns
of SCD in patients with OSA compared with the general
population. We had previously shown that individuals with
OSA had an increased risk of SCD from 10 PM to 6 AM and
that individuals without OSA had a diurnal pattern of sudden
death that was similar to that expected in the general pop-
ulation, with a peak between 6 AM and noon (9). In that study,
individuals with OSA had a 2.6-fold risk of nocturnal SCD,
and the severity of OSA correlated with the magnitude of this
risk. Our present ﬁndings suggest that this increase of SCD
during the night may represent “excess” deaths, rather than
simply a shift of SCD from other times of the day to the night.
Causes of SCD. The mechanism of SCD is usually
considered to be a ventricular arrhythmia. However, a number
of other processes can mimic the unexpected and rapidly fatal
presentation required by the deﬁnition of SCD. In our study
sample, 13% of SCD were attributed directly to myocardial
infarction, which may be explained by fatal sequelae such as
cardiogenic shock or mechanical complications, as well asTable 6
Independent Predictors of SCD in Subjects With OSA
(Results of Multivariate Regression)
HR 95% CI p Value
Age, yrs 1.02 1.002–1.04 0.03
Hypertension 1.57 1.01–2.44 0.04
Coronary artery disease 5.88 3.64–9.48 <0.001
Cardiomyopathy or heart failure 7.20 4.71–11.0 <0.001
Ventricular ectopy or NSVT 4.08 1.64–10.14 0.002
Sleep parameters
Apnea-hypopnea index, per 10 1.06 1.0–1.13 0.05
Lowest nocturnal O2 saturation,
per 10%
1.13 1.0–1.29 0.05
Abbreviations as in Tables 3, 4, and 5.
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615potential misclassiﬁcation due to unrecognized ventricular
arrhythmias. SCD may also result from other cardiovascular
events, such as massive pulmonary embolism (1 subject in our
study), aortic dissection, and subarachnoid hemorrhage.
Another less recognized but potentially important cause of
sudden death in patients with OSA is apnea itself. An
obstructive apnea may not terminate due to ineffective arousal
mechanisms related to impaired chemosensitivity, which
leads to profound cerebral hypoxemia and death. Three such
cases, with polysomnographic and electrocardiographic
monitoring, have been described (23,24).
Study limitations. To mitigate referral bias, we restricted
the study sample to state residents. The study sample was
drawn from individuals referred to the sleep disorder center
at our institution, which may limit generalization of our
ﬁndings to nonselected community residents. The average
annual rate of SCD in the study population was 0.27%,
higher than the estimated annual risk of SCD in the general
population of 0.1% to 0.2% (12), thus reﬂecting the referral
pattern to our sleep disorders center.
The limits of a retrospective analysis are inherent to this
study, including the 1-time assessment of subject comor-
bidities at the time of their sleep studies and use of
dichotomous variables to classify the presence or absence of
speciﬁc conditions that exist on a spectrum of risk, such as
cholesterol levels or blood pressure. Also, other relevant
comorbidities may have existed. The retrospective analysis
limits the interpretation of the results of continuous positive
airway pressure therapy in the subgroup analysis of indi-
viduals with OSA. The medical records rarely contained
data regarding the frequency, duration, or effectiveness of
continuous positive airway pressure therapy in our subjects,
and continuous positive airway pressure machines that assess
compliance were generally not used during the study years.
Another limitation relates to the challenges of classifying
SCD. We used standardized methods using the best avail-
able data and current deﬁnitions to conﬁrm or exclude
diagnoses of SCD in our study sample. The use of state
records and death certiﬁcate data has been performed and
validated in prior epidemiological studies of SCD, including
our regional population (25–27). We improved on past
methods by directly reviewing every available death record
from the larger population to conﬁrm the diagnosis based on
current deﬁnitions of SCD (12).
Last, a possible limitation is related to the interpretation
of ICD therapies for SCD classiﬁcation. A subanalysis of an
ICD trial has questioned the basis for using ICD therapy as
a surrogate for SCD (28). Our methods are in accordance
with the vast majority of ICD trials, in which ICD therapy
has been considered a resuscitated SCD.
Conclusions
In this cohort study of 10,701 adults referred to a sleep
disorders clinic and undergoing diagnostic polysomnography
for the ﬁrst time, the risk of incident SCD after an averageof 5 years was signiﬁcantly and independently associated
with OSA, based both on the frequency of apneas and
hypopneas and on the severity of nocturnal oxygen desatu-
rations. These ﬁndings should encourage ongoing research
of the mechanisms of SCD in individuals with OSA, as well
as the development of clinical trials of OSA therapy in select
populations at risk for SCD.Reprint requests and correspondence: Dr. Virend K. Somers,
Mayo Clinic College of Medicine, Division of Cardiovascular
Diseases, 200 First Street, SW, Rochester, Minnesota 55905.
E-mail: somers.virend@mayo.edu.REFERENCES
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